Health care is expensive, even for those with insurance. My treatment with the breast cancer drug Herceptin cost $5,000 every three weeks for 52 weeks. Insurance paid 80 percent; I was responsible for 20. That's $1,000 every three weeks. Not exactly affordable.

What many of us don't know is that we can play an active role in cutting our health care bills. We can shop around for everything, for example. Before filling a prescription, consider comparing prices offered at mail-order and online pharmacies with those of larger retailers. You may even find that mom and pop shops offer competitive rates since they can set their own pricing. Don't forget about generic drugs too. Ask your doctor if a generic version of your medication is just as good as a brand name drug. If so, go for the price break.

Did you know that lab work is more expensive if you get it at a hospital? Ask your doctor for other trustworthy locations and save a few bucks.

It is important to question your physician about the prescriptions you are given. Most doctors will talk to you about the medication prescribed, but it is still important that you know what you're taking and ask appropriate questions.

• Know the name of the drug. This will enable you to look up information about the drug on your own. It will also enable you to discuss the drug with your doctor or another doctor for a second opinion.
• What is the purpose of the drug? This information will help you to know and understand what this drug is supposed to do and will let you know if the treatment is actually working.
• What are the side effects? It is helpful to be aware of the most common side effects. All drugs have some side effects. Information about side effects can be obtained by asking your doctor or pharmacist or consulting a reliable reference.

A generic drug is exactly the same dosage, safety, strength and quality as a brand named drug. Generic drugs also do not take longer to work in the body, again, its the same ingredients as the name you are more familiar.

The reason generic drugs are cheaper is because the makers of these drugs don't have the costs of the original developer of the drug. When the patent on the developer expires, 20 years, other manufactures can introduce competitive generic versions to the FDA for approval. This also creates greater competition in the industry once generic drugs are approved and keeps costs lower.

A great place to go is here for more information on your generic drugs.

I had no idea my February 10 post Some children's bath products linked to cancer would spark such great debate. At the very moment I write, the post has received more than 64,000 hits and 70 comments.

I must admit when the comments started rolling in, I was a bit nervous. Even though I merely reported the facts on this topic, had no claim to any of the information, and didn't even share my opinion on the matter, the highly charged words written by so many well-meaning readers made me feel a bit like I was caught in the middle, like I started an argument and needed to jump back in, sort things out, and create harmony among those responding to my words.

But then I realized debate is not such a bad thing. It sheds light on all sorts of valid viewpoints. It educates. It raises awareness. And that's what cancer causes are all about.

Having read all the comments that now are officially assigned to this one post, I am so much more enlightened than when I summarized the story I came across revealing that some bath products contain a bit too much of a chemical called 1,4-dioxane, a probable human carcinogen that is already known to cause cancer in animals.

All I really knew at the time I wrote the post is that the FDA has no regulation over this chemical and that cosmetic companies must monitor themselves. Some don't do such a good job, and herein lies the debate.

Some readers say big deal, what's the harm really in a little extra dash of chemical in a whole tub of water. Perhaps if our children soaked all day for many days in this chemical, cancer might strike. But a quick bath with a tiny trace of 1,4-dioxane is not likely to do any harm. One reader wrote that we shouldn't stress so much about headlines that scare us into believing everything causes cancer, that we'll probably live a whole lot longer just living our lives free of constant worry.

Another camp of readers say a little bit of something bad is still too much. Over the course of a lifetime, how do we know our children won't pay for our mistaken belief that this hype is just -- hype. Some cancer surviving readers wonder if their cancer was caused by their plentiful childhood bubble baths. And some go to great lengths to find natural, organic, chemical-free products, whatever the financial cost.

A few consultants for these natural products left their own comments, claiming to help those consumed with anxiety. Others scolded these business people for capitalizing on the fears of others with products that have not been proved any safer.

There are advocates of moderation who wrote. And individuals seeking more information. And people who located resources for others to investigate.

There is indeed a rich commentary on the link between bath products and cancer that follows one short post I wrote late one night, after my own children were bathed -- with Dove soap and generic shampoo -- and put to bed. And I am indeed happy to know my small contribution on the topic has generated such a powerful windfall of thought and concern.

The world's largest drug maker -- Pfizer Inc. -- announced Monday it will cut 10,000 jobs and close at least five facilities due to fierce competition from generic drug makers. The goal, says Pfizer spokespeople, is to whittle away annual costs by $2 billion by the end of the year -- to combat the prediction that the company will lose 41 percent of its sales to generic drugs between 2010 and 2012.

Pfizer's other obstacles include expiring drug patents -- costing Pfizer about $14 billion in revenues between 2005 and 2007 -- as well as demands for lower prices by insurers and large purchasers, and repeated requests for evidence of products' worth.

The 10,000 layoffs amount to 10 percent of the company's global workforce and will take jobs from 2,200 United States employees. The company will cut 20 percent of its European sales force, will close three research sites in Michigan and two manufacturing plants in New York and Nebraska, and is considering selling a manufacturing site in Germany and closing two research sites in Japan and France. In the midst of all of this, the company will focus its efforts on transforming the way they do business.

"I believe we must transform the way we've done business in the past in order to be more successful in the future," said Jeffrey Kindler, CEO and chairman of Pfizer. " Incremental evolution is not enough. Fundamental change is imperative -- and it must happen now."

Pfizer's Monday announcement is the second declaration of budget cuts. A previous announcement has the company -- the maker of cancer drugs Aromasin, Ellence, Camptosar, and Sutent -- slashing costs by $4 billion a year until 2008.

Zofran (Ondansetron) tablets are used to prevent nausea and vomiting associated with chemotherapy. I remember Zofran costing about $30 a tablet back in 2002 when I was receiving chemotherapy. I was lucky I had insurance that covered the high cost of the drugs I needed. Yesterday the Food and Drug Administration approved the first generic versions of Zofran.

Gary j. Buehler, director, Office of General Drugs, says "This approval will result in significant savings for the American public. Generic drugs are safe and effective alternatives to brand name drugs and undergo a thorough scientific and regulatory review".

Generic drugs usually cost a fraction of the price of the brand-name drugs.

Two months ago, Wal-Mart launched its $4 dollar generic prescription drug program in Tampa, Florida. Two weeks ago, the program was expanded to include all Wal-Mart and Sam's Club pharmacies in 14 additional states -- Alaska, Arizona, Arkansas, Delaware, Illinois, Indiana, Nevada, New Jersey, New Mexico, New York, North Carolina, Oregon, Texas and Vermont.

314 generic prescription drugs, accounting for 25 percent of prescriptions it currently dispenses in its pharmacies nationwide, are available under the $4 dollar program.

For those with health insurance, the typical co-pay for the 314 generic drugs in Wal-Mart's $4 dollar generic prescription drug program cost between $5 dollars and $10 dollars. While the savings might not seem like much for people with health insurance, the co-payments can add up each month. For those on limited incomes, any savings is welcome relief. For the 46 million uninsured patients who live in one of the 15 states where this program is available, the savings can amount to much more, and may be one of the few times they have been offered a break when it comes to medical costs.

The generic drug list is available as a PDF document here.